Literature DB >> 778772

Neonatal pancreatic beta-cell hyperplasia: report of a case with failure of diazoxide and benefit of early subtotal pancreatectomy.

W L Crowder, N K Maclaren, R L Gutberlet, J L Frost, G R Mason, M Cornblath.   

Abstract

A newborn infant with pancreatic beta-cell hyperplasia had persistent hypoglycemia due to hyperinsulinism. After medical management, including the use of diazoxide and constant glucose infusions had proved ineffective, a subtotal pancreatectomy was curative. Cumulative experience seems to indicate that there should be little delay in performing a subtotal pancreatectomy when aggressive medical management cannot maintain normoglycemia in a neonate.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 778772

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

1.  Beta cell nesidioblastosis.

Authors:  K Becker; U Wendel; H Przyrembel; M Tsotsalas; H Münterfering; H J Bremer
Journal:  Eur J Pediatr       Date:  1978-01-17       Impact factor: 3.183

2.  Neonatal and infantile hypoglycemia due to insulin excess: new aspects of diagnosis and surgical management.

Authors:  C G Thomas; L E Underwood; C N Carney; J L Dolcourt; J J Whitt
Journal:  Ann Surg       Date:  1977-05       Impact factor: 12.969

3.  Experience with 95% pancreatectomy and splenic salvage for neonatal nesidioblastosis.

Authors:  L W Martin; F C Ryckman; C A Sheldon
Journal:  Ann Surg       Date:  1984-09       Impact factor: 12.969

4.  Hyperinsulinemic hypoglycemia of the neonate associated with persistent fetal histology and function of the pancreas.

Authors:  D W Shermeta; G Mendelsohn; J A Haller
Journal:  Ann Surg       Date:  1980-02       Impact factor: 12.969

5.  Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia.

Authors:  A Aynsley-Green; J M Polak; S R Bloom; M H Gough; J Keeling; S J Ashcroft; R C Turner; J D Baum
Journal:  Arch Dis Child       Date:  1981-07       Impact factor: 3.791

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.